Improved HbA1c and Body Weight in GADA-Positive Individuals Treated With Tirzepatide: A Post Hoc Analysis of SURPASS.
Saved in:
| Title: | Improved HbA1c and Body Weight in GADA-Positive Individuals Treated With Tirzepatide: A Post Hoc Analysis of SURPASS. |
|---|---|
| Authors: | Peters AL; University of Southern California Clinical Diabetes Program, Keck School of Medicine of the University of Southern California, Los Angeles, Los Angeles, CA 90033, USA., Buzzetti R; Department of Experimental Medicine, Sapienza University of Rome, Rome 00160, Italy., Lee CJ; Eli Lilly and Company, Indianapolis, IN 46285, USA., Pavo I; Eli Lilly and Company, Indianapolis, IN 46285, USA., Liu M; Tigermed-BCM Inc, Somerset, NJ 08873, USA., Karanikas CA; Eli Lilly and Company, Indianapolis, IN 46285, USA., Paik JS; Eli Lilly and Company, Indianapolis, IN 46285, USA. |
| Source: | The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2025 Mar 17; Vol. 110 (4), pp. e962-e969. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Internet ISSN: 1945-7197 (Electronic) Linking ISSN: 0021972X NLM ISO Abbreviation: J Clin Endocrinol Metab Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1945-7197 |
|---|---|
| DOI: | 10.1210/clinem/dgae372 |
